Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Time for a new uptick, running leg Up

<< Previous

Bullboard Posts

Next >>

Comment by canadafanon Oct 12, 2021 4:19pm

233 Views

Post# 33998677

RE:RE:Time for a new uptick, running leg Up

Oncy does not need any ATM $ for a year.
They have cash runway into Q1 of 2023.
so......lots of upside.
FYI, some publications out of Europe naming ONC alongside others as "the new wave of cancer treatments" & huge price upside.
relax, put your seatbelt on & enjoy the ride.

<< Previous

Bullboard Posts

Next >>

A Look into the Future of Chronic Pain Management